YD Bio Limited (YDES)

YD Bio Revenue

YD Bio had revenue of $423.25K in the quarter ending June 30, 2026, with 196.62% growth. This brings the company's total for the last twelve months to $1.24M, up 147.92% year-over-year. In the year 2025, YD Bio had annual revenue of $596.82K with 16.94% growth. That makes YD Bio the 43,275th largest company in the world by revenue and 5,997th in the United States.

• Revenue (ttm): $1.24M
• Revenue Growth: +147.92%
• P/S Ratio: 345.21
• Revenue / Employee: $82,621
• Employees: 15
• Market Cap: 427.82M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Sales of Medical and Other Related Products Segment 561.82K 94.1%
• Research and Development of Sales of Contact Lenses 35.00K 5.9%

Fiscal year ended Dec 31, 2025 See the full YD Bio breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	596.82K	86.46K	16.94%
Dec 31, 2024	510.36K	160.23K	45.76%
Dec 31, 2023	350.13K	-13.99K	-3.84%
Dec 31, 2022	364.12K	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 27, 2026

Data Sources Report a data error